These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19383279)

  • 1. Just a small, proof-of-concept study.
    Novack GD
    Ocul Surf; 2009 Apr; 7(2):111-2. PubMed ID: 19383279
    [No Abstract]   [Full Text] [Related]  

  • 2. Less is more: the human microdosing concept.
    Garner RC
    Drug Discov Today; 2005 Apr; 10(7):449-51. PubMed ID: 15809185
    [No Abstract]   [Full Text] [Related]  

  • 3. Biomarkers and proof of concept.
    Ferber G
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():35-40. PubMed ID: 12575486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for success in drug development.
    Wardell WM
    Retina; 2005 Dec; 25(8 Suppl):S100-S102. PubMed ID: 16374309
    [No Abstract]   [Full Text] [Related]  

  • 5. Celebrating the SSCI: the drug discovery pathway: challenges and pitfalls.
    Bennett JC
    Am J Med Sci; 2003 Dec; 326(6):329-32. PubMed ID: 14671495
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimizing the preclinical/clinical interface: an Informa Life Sciences conference 12-13 December, 2006, London, UK.
    Cavero I
    Expert Opin Drug Saf; 2007 Mar; 6(2):217-24. PubMed ID: 17367268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy: the role of chemistry, manufacturing, and controls in pharmaceutical drug development.
    DiFeo TJ
    Drug Dev Ind Pharm; 2004 Mar; 30(3):247-57. PubMed ID: 15109024
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of inhibitory drug interactions during drug development: genetic polymorphisms must be considered.
    Lee LS; Nafziger AN; Bertino JS
    Clin Pharmacol Ther; 2005 Jul; 78(1):1-6. PubMed ID: 16003286
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Biomarkers Forum--Harnessing the Potential of Biomarkers from Translational Research, throughout Clinical Trials. 13-14 September 2007, Prague, Czech Republic.
    Guergova-Kuras M
    IDrugs; 2007 Nov; 10(11):782-3. PubMed ID: 17968758
    [No Abstract]   [Full Text] [Related]  

  • 10. Industry Perspective on Biomarker Development and Qualification.
    Gerlach CV; Derzi M; Ramaiah SK; Vaidya VS
    Clin Pharmacol Ther; 2018 Jan; 103(1):27-31. PubMed ID: 29143971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies in selecting an agent for clinical trials.
    Peck RW
    Ann N Y Acad Sci; 1997 Aug; 823():319-27. PubMed ID: 9292060
    [No Abstract]   [Full Text] [Related]  

  • 12. Applications of metabolomics in drug discovery and development.
    Wishart DS
    Drugs R D; 2008; 9(5):307-22. PubMed ID: 18721000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ultimate model organism: progress in experimental medicine.
    Littman BH; Williams SA
    Nat Rev Drug Discov; 2005 Aug; 4(8):631-8. PubMed ID: 16056389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative image analysis: software systems in drug development trials.
    Eckstein F; Englmeier KH
    Drug Discov Today; 2003 Oct; 8(20):922-3. PubMed ID: 14554153
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved early clinical development through human microdosing studies.
    Wilding IR; Bell JA
    Drug Discov Today; 2005 Jul; 10(13):890-4. PubMed ID: 15993808
    [No Abstract]   [Full Text] [Related]  

  • 16. The brains behind blockbusters.
    Couzin J
    Science; 2005 Jul; 309(5735):728. PubMed ID: 16051786
    [No Abstract]   [Full Text] [Related]  

  • 17. The test of public scrutiny.
    Mallinckrodt CH
    Pharm Stat; 2006; 5(4):249-52. PubMed ID: 17219626
    [No Abstract]   [Full Text] [Related]  

  • 18. Next-generation vaccines - An IBC Conference. Harnessing innovative technologies and processes to speed up your research, development & production of novel vaccines part 2.
    Yuan L
    IDrugs; 2008 Sep; 11(9):633-5. PubMed ID: 18763210
    [No Abstract]   [Full Text] [Related]  

  • 19. Next-generation vaccines - An IBC Conference. Harnessing innovative technologies and processes to speed up your research, development & production of novel vaccines part 1.
    Yuan L
    IDrugs; 2008 Sep; 11(9):630-2. PubMed ID: 18763209
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical nanotechnology: shortening clinical trials and regulatory pathways?
    Ferrari M; Downing G
    BioDrugs; 2005; 19(4):203-10. PubMed ID: 16128604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.